The Type 2 Asthma Mediator IL-13 Inhibits Severe Acute Respiratory Syndrome Coronavirus 2 Infection of Bronchial Epithelium-Reference-Cited by-同舟云学术

The Type 2 Asthma Mediator IL-13 Inhibits Severe Acute Respiratory Syndrome Coronavirus 2 Infection of Bronchial Epithelium

Published:2022-04 Issue:4 Volume:66 Page:391-401
ISSN:1044-1549
Container-title:American Journal of Respiratory Cell and Molecular Biology
language:en
Short-container-title:Am J Respir Cell Mol Biol

Author:

Bonser Luke R.¹^ORCID,Eckalbar Walter L.¹²³,Rodriguez Lauren³,Shen Jiangshan¹,Koh Kyung Duk¹^ORCID,Ghias Khadija¹,Zlock Lorna T.⁴,Christenson Stephanie²,Woodruff Prescott G.²⁵⁶,Finkbeiner Walter E.⁴,Erle David J.¹³⁵⁶⁷^ORCID

Affiliation:

1. Lung Biology Center, and

2. Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine,

3. UCSF CoLabs,

4. Department of Pathology,

5. Cardiovascular Research Institute,

6. ImmunoX Initiative, and

7. Institute for Human Genetics, University of California, San Francisco, California

Funder

National Institutes of Health

Publisher

American Thoracic Society

Subject

Cell Biology,Clinical Biochemistry,Pulmonary and Respiratory Medicine,Molecular Biology

Link

https://www.atsjournals.org/doi/pdf/10.1165/rcmb.2021-0364OC

Reference51 articles.

1. Factors associated with COVID-19-related death using OpenSAFELY

2. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

3. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

4. Global absence and targeting of protective immune states in severe COVID-19

5. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 in patients with airways disease: COPD, asthma and bronchiectasis;COVID-19: An Update;2024-09-01

2. IL-13 decreases susceptibility to airway epithelial SARS-CoV-2 infection but increases disease severity in vivo;2024-07-04

3. COVID-19 and Asthma Onset in Children;Pediatrics;2024-04-12

4. The Role of Cytokines and Molecular Pathways in Lung Fibrosis Following SARS-CoV-2 Infection: A Physiopathologic (Re)view;Biomedicines;2024-03-13

5. Asthma and clinical outcomes of COVID-19 in a community setting;Public Health;2024-01